Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice-Reference-Cited by-同舟云学术

Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice

Published:2016-10 Issue:10 Volume:65 Page:1508-1521
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Sousa-Lima Inês,Park Shin-Young,Chung Michelle,Jung Hyun Ju,Kang Min-Cheol,Gaspar Joana M.,Seo Ji A.,Macedo M. Paula,Park Kyong Soo,Mantzoros Christos,Lee Seung-Hoon,Kim Young-Bum

Funder

FCT

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference53 articles.

1. Obesity and diabetes in the developing world—a growing challenge;Hossain;N Engl J Med,2007

2. Obesity, inflammation, and the gut microbiota;Cox;Lancet Diabetes Endocrinol,2015

3. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?;Tsai;Diabetes,2015

4. Obesity-driven disruption of haematopoiesis and the bone marrow niche;Adler;Nat Rev Endocrinol,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylsulfonylmethane ameliorates metabolic-associated fatty liver disease by restoring autophagy flux via AMPK/mTOR/ULK1 signaling pathway;Frontiers in Pharmacology;2023-11-30

2. Sustained Delivery of Methylsulfonylmethane from Biodegradable Scaffolds Enhances Efficient Bone Regeneration;International Journal of Nanomedicine;2022-10

3. N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19;Advances in Pharmacological and Pharmaceutical Sciences;2022-08-10

4. Methylsulfonylmethane and Sesame Seed Oil Improve Dyslipidemia and Modulate Polyunsaturated Fatty Acid Metabolism in Two Mouse Models of Diabetes;Journal of Medicinal Food;2022-06-01

5. Methylsulfonylmethane protects against ethanol-induced brain injury in mice through the inhibition of oxidative stress, proinflammatory mediators and apoptotic cell death;International Immunopharmacology;2022-05